Announcements Trials
Browse Landscape

Phase

Phase 2 104Phase 1/2 52Phase 1 34Phase 3 13Phase NA 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Thoracic 1Sarcoma 1Other hematologic neoplasm 1Myeloid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 372Neoplasms 263Prostatic Neoplasms 188Lung Neoplasms 137Colorectal Neoplasms 128Head and Neck Neoplasms 76Colonic Neoplasms 67Pancreatic Neoplasms 63Carcinoma, Non-Small-Cell Lung 63Carcinoma, Hepatocellular 61Uterine Cervical Neoplasms 57Multiple Myeloma 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Neoplasm Metastasis 51Leukemia, Myeloid, Acute 50Brain Neoplasms 48Liver Neoplasms 44Rectal Neoplasms 42Melanoma 42Motor Activity 41Lymphoma, Non-Hodgkin 41Lymphoma 39Leukemia 38Pain 37Ovarian Neoplasms 36Hodgkin Disease 36Fatigue 34Depression 34Barrett Esophagus 34Lymphoma, Follicular 33

Interventions

veliparib 1Standard of Care 1Practice Guidelines as Topic 1Palliative Care 1Magnetic Resonance Imaging 1Lapatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Has results × Triple Negative Breast Neoplasms × Clear all
NCT02158507 2026-01-22

Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

University of Alabama at Birmingham

Phase NA Completed
20 enrolled 10 charts
Breast

Triple Negative Breast Neoplasms

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Stanford University

Phase NA Completed
128 enrolled 24 charts
BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT03750240 2022-08-24

Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy

NYU Langone Health

Phase NA Terminated
2 enrolled 5 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡